Ask The Recruiter

Vistagen Therapeutics, Inc.

Pay Change, last update 4 months ago

Pharma biotech · Headquarters United States

Everything we hold on Vistagen Therapeutics, Inc., newest first. Every line links to the filing or report it came from.

3 updates tracked
2 leadership changes
20 Feb 2026 tracked since
United States where
  1. 2026-04-13
    Pay Change Leadership moves

    Vistagen Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change

    Executives at Vistagen Therapeutics in South San Francisco receive stock options as part of a retention strategy.

    United States · Official Filing · SEC EDGAR

  2. 2026-03-31
    Pay Change Pay and benefits

    VISTAGEN THERAPEUTICS, INC.: $1,212,560 total compensation for the principal executive officer, fiscal year ended 2026-03-31

    Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.

    United States · Official Filing · SEC EDGAR (pay-versus-performance)

  3. 2026-02-20
    Headcount Not Stated Leadership moves

    Vistagen Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change

    Vistagen Therapeutics seeks a new board member in South San Francisco after a director's resignation.

    United States · Official Filing · SEC EDGAR

Cite this pageVistagen Therapeutics, Inc.. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/vistagen-therapeutics/ Licensed CC BY 4.0; every record links to the document behind it.

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker